Introduction {#Sec1}
============

While adult hepatocytes are normally quiescent, they show phenomenal replicative potential when parenchymal loss occurs. This has made the liver an excellent model for studying organ regeneration^[@CR1]--[@CR4]^. The regenerative process is typically divided into the priming, proliferating and termination phases, occurring approximately at first, third and seventh days after resection, respectively^[@CR5]^. Clinically, the regenerative ability of livers provides the cornerstone of many surgical treatments for liver diseases; resection of diseased portions seems to improve survival^[@CR6]^. However, extensive removal of liver parenchyma, which may be necessary in some cases, may overcome the functional reserve of the remaining hepatocyte population, leading to decompensation, failure and even mortality^[@CR7]^. To avoid this complication, pre-operative iatrogenic induction of hepatocyte proliferation can be attempted to increase the future remnant tissue's resilience against the anticipated surgical volume loss^[@CR7]^.

Several options are available to induce the regenerative capacity of the liver. While cellular proliferation may be chemically induced^[@CR8]^, surgical induction procedures provide additional advantages such as intraoperative assessment of the extent of disease, anatomically-targeted induction, and radical disease resection^[@CR7]^. These procedures include: Partial hepatectomy (PH), intraoperative portal vein ligation (PVL), percutaneous portal vein embolization (PVE), and associated liver partition and portal vein ligation for staged hepatectomy (ALPPS). Rates at which the remaining tissue regenerates differ between procedures. For example, three to twelve weeks are needed after PVL to achieve adequate regenerative volume compared to 7--8 days in ALPPS^[@CR9]^. Similarly, Schlegel *et al*. showed a significantly accelerated increase in future liver remnant volume after ALPPS than PVL (1 vs. 4 days, respectively)^[@CR10]^.

Contrary to other organs where dedicated stem cells replace injured tissues^[@CR11]^, functional hepatocytes appear to be responsible for liver regeneration^[@CR12]^. Therefore, major shifts in gene activation and transcription patterns are needed for the transformation from fully-differentiated to highly-proliferative cells. Interestingly, while eventual replacement of lost tissue is a common outcome, contemporary evidence suggests that genomic and transcriptomic alterations may vary based on regeneration-driving factors^[@CR8]^. Indeed, systematic analysis of genome-wide shifts can identify either common or specific signatures of different procedures, which may provide insights into the key regulators of such a complex process^[@CR13]^. Additionally, the signatures may prove clinically useful in gauging patients' treatment responses, planning further treatments, and providing prognostic information.

To date, several reports have investigated the effect of surgical procedures on gene expression patterns in regenerating rat livers after PH^[@CR14]^, PVL^[@CR15]^, and ALPPS when compared with controls^[@CR10]^, as well as PVL vs. ALPPS^[@CR10],[@CR16],[@CR17]^. However, to our knowledge, no study has explored the global gene expression patterns in regenerating livers after different regeneration-promoting surgical procedures and performed inter-procedural comparison. Using the power of next-generation RNA sequencing (RNAseq), we provided an overarching comparative analysis of differentially-regulated genes among three surgical groups (PH, PVL, ALPPS versus Sham) in regenerating rat livers, at early regenerating phase (i.e. 24 hours) and late-stage (i.e. 96 hours) post-operatively. Furthermore, we identified both unique and shared molecular mechanisms and signaling pathways for liver regeneration in the investigated surgical procedures.

Materials and Methods {#Sec2}
=====================

Animals {#Sec3}
-------

Six to 8 weeks old Male Sprague--Dawley rats weighing 200--250 g were obtained from the Charles-River Laboratories UK Ltd. The animals were housed in an alternating light and dark room with controlled temperature and relative humidity (23 ± 2 °C, 50 ± 10%). They were given standard laboratory rodent chow and free water access, as detailed previously^[@CR9]^. All the experiments were approved by the local ethics committee (University College London) and conducted according to Home Office guidelines under the UK Animals and Scientific Procedures Act 1986.

Experimental design and animal groups {#Sec4}
-------------------------------------

Rats were divided into groups and anesthetized under isoflurane administration. A middle line incision was performed on the abdomen. (1) Sham group: Abdomen was closed after manipulation of the liver hilum; (2) PVL group: Portal vein ligation was performed on all branches except the branch to the right median lobe using a size 7--0 nylon thread; and (3) ALPPS group: selective portal vein ligation and liver parenchymal partitioning were performed (4) PH group: A 5--0 nylon thread was tied tightly around the median and left lateral lobes (\~70% of the total liver mass) and both lobes were then resected, as described previously^[@CR9]^. There were three rats for each group at each time point (24 h and 96 h). The detail of surgical operations and experimental grouping is provided in our previous study^[@CR9]^.

RNA sequencing analysis {#Sec5}
-----------------------

TRIzol (Invitrogen) was used for isolation of total RNA (15 µg) that was utilized for purifying the poly(A)-containing mRNA molecules, RNA amplification, and synthesis of double-stranded cDNAs according to Illumina's TruSeq RNA Sample Prep guidelines (San Diego, CA). Multiplexed samples were sequenced at 43 bp length on Illumina-based Technology. Triplicate biological replicates were performed for each group. The paired-end reads of each sample were aligned to the rat genome (rn5) using the TopHat^[@CR18]^. Transcript abundance was estimated by Cufflinks^[@CR19]^. The quantification and normalization (DESeq method^[@CR20]^) and further downstream analyses of identification of differentially expressed genes (DEGs) were done by using Strand NGS 2.7 (Strand Life Sciences, India) and PARTEK Genomics Suite (Partek Inc., St. Louis, MO, USA). Significantly regulated genes across different operation types (ALPPS, PVL, PH, and Sham) and two time points (24 h and 96 h) were determined using two-factor analysis of variance (ANOVA) by taking operation type, time and their interactions into the statistical model. Genes exhibiting false discovery rate (FDR)-adjusted *P* value\<0.05 and the absolute fold changes (FC) \> 2 were considered significant.

Functional pathway, upstream regulator, and network analyses {#Sec6}
------------------------------------------------------------

Functional, pathway, and gene ontology (GO) enrichment analysis were performed using Database for Annotation, Visualization and Integrated Discovery (DAVID)^[@CR21]^, Protein Analysis Through Evolutionary Relationships (PANTHER™) classification systems and Ingenuity Pathways Analysis (IPA) (QIAGEN Inc., <https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis>). We also performed upstream regulator, canonical pathways, and gene network analyses using IPA and Network Analyst^[@CR22]^. The DEGs lists for each surgical procedure for different time points were mapped to its corresponding gene object in the Ingenuity pathway knowledge base and protein-protein interaction networks. A right-tailed Fisher's exact test was used to calculate a p-value determining the probability that the biological function (or pathway) assigned to that data set is explained by chance alone. The IPA upstream regulator analysis predicts the upstream transcriptional regulators based on the Ingenuity® Knowledge Base by examining how many known targets of the upstream regulators are present in the differentially expressed gene list. An overlap p‐value, based on significant overlap between genes in the list and known targets regulated by the transcriptional regulator, and an activation z‐score are computed. The predicted activation state and activation z-score are based on the direction of fold change values that we observed in the gene expression data. The activation z‐score is to infer likely activation states, "activated" or "inhibited", of upstream transcriptional regulators. It was considered significantly activated (or inhibited) with an overlap p-value ≤ 0.05 and an z-score ≥ 2.0 (or ≤ −2.0).

Results {#Sec7}
=======

Global gene expression changes in regenerating livers after ALPPS, PVL and PH {#Sec8}
-----------------------------------------------------------------------------

Global transcriptome changes associated with the surgical procedures at each time point were measured by RNAseq approach. The analysis generated 14,989,372 to 120,655,689 reads, which represented 88.5% of the genome (rn5), and 31,399 transcripts (Supplementary Table [S1](#MOESM1){ref-type="media"}). There were 2,014 genes that showed a significant change in at least one surgical procedure (with respect to sham group) at either of the two time points (Fig. [1a](#Fig1){ref-type="fig"}). The variation in the data matrix was mostly due to the time effect, followed by the operation type (Fig. [1b](#Fig1){ref-type="fig"}). Principal components analyses (PCA) and unsupervised hierarchical clustering separated the samples according to two time points (24 h and 96 h) and surgical procedure types (Fig. [1c,d](#Fig1){ref-type="fig"}, respectively). Genes involved in cell cycle, mitosis, developmental process, and DNA replication were up-regulated in three surgical groups at 24 h with highest increase was observed in PH and ALPPS compared to the PVL group, which were later repressed at 96 h (Fig. [1d](#Fig1){ref-type="fig"}). Macrophage activation, cell adhesion, immune process, ion transport, and lipid metabolic process related genes had low level of expression at 24 h, but were up-regulated at 96 h post-operation (Fig. [1d](#Fig1){ref-type="fig"}).Figure 1(**a**) Venn diagrams representing the differentially expressed genes specific or common among ALPPS, PH and PVL at 24 h and 96 h, respectively. **(b)** Sources of variation in the data matrix. The x-axis shows the components of the 2-way ANOVA model and the y-axis shows the mean signal to noise ratio. **(c)** Unsupervised PCA analysis. Different colors indicate different surgical types and shapes indicate different time points. **(d)** Two-dimensional hierarchical clustering of genes, that are significant in at least one surgical procedure (with respect to sham group) at any of the two time points, and samples. The figure shows the most associated GO biological processes for each cluster of genes. Red and green denote highly and weakly expressed genes, respectively.

Inter-procedural similarities/differences at 24 h and 96 h post operations {#Sec9}
--------------------------------------------------------------------------

Since the time had the greatest effect on the expression, we next compared the transcriptomes of the procedures at each time point separately. Differentially expressed genes (DEGs) that are specific or commonly dysregulated between the procedures at 24 h and 96 h were obtained using the Venn diagram approach (Fig. [1a](#Fig1){ref-type="fig"}). The PCA and hierarchical clustering analyses of the significant genes (FDR \< 5% and FC \> 2) separated the samples according to the surgical types at each time points (Supplementary Fig. [S1](#MOESM1){ref-type="media"}).

At 24 h, the PH vs Sham produced the largest number of DEGs, followed by ALPPS vs Sham (Fig. [1a](#Fig1){ref-type="fig"}, Supplementary Table [S2](#MOESM1){ref-type="media"}). There were 1242 DEGs for the PH (703↑ up-regulated, 539↓ down-regulated), 814 for the ALPPS group (536↑, 278↓), and 539 for the PVL (428↑, 111↓), and 411 DEGs (351↑, 60↓) were common to all surgical procedures. The arrow represents an increase (↑) or decrease (↓) in fold compared to Sham. Comparing different procedures, 123, 542, and 71 genes were specifically expressed in ALPPS, PH, and PVL, respectively (Fig. [1a](#Fig1){ref-type="fig"}). There were more DEGs commonly shared between the ALPPS and the PH than with the PVL, especially at 24 h. The list of DEGs shared and unique to each procedure is given in Supplementary Table [S2](#MOESM1){ref-type="media"}. The ALPPS showed more similar expression pattern to the PH than the PVL especially at the early phase of the regeneration at 24 h post operation (Supplementary Fig. [S1](#MOESM1){ref-type="media"}).

We further performed an extensive comparison of functional enrichment and gene networks for the three surgical procedures using different bioinformatics tools to further investigate molecular similarities/differences among the procedures. Gene ontology enrichment analysis revealed that genes related to cell cycle, mitotic cell cycle, M phase, and DNA replication and repair were significantly enriched among the up-regulated genes at 24 h for all surgical procedures (Supplementary Fig. [S1](#MOESM1){ref-type="media"}). However, genes related to oxidation-reduction, triglyceride, and steroid metabolic processes were the most critically enriched among the down-regulated genes in ALPPS and PH only (Fig. [2a](#Fig2){ref-type="fig"}, Table [1](#Tab1){ref-type="table"}, and Supplementary Fig. [S4](#MOESM1){ref-type="media"}).Figure 2Bar chart of the most significant GO biological processes that are associated with up- and down-regulated genes for each surgical procedure at 24h (**a**) and 96h (**b**). X-axis represents the statistical significance of the enrichment (--log10(p-value)). Color-coding represents different surgical types.Table 1GO Biological Processes that are enriched in DEGs in ALPPS, PVL and PH.GO Biological Process Term24 hours96 hoursALPPSPVLPHALPPSPVLPHFE\*p-valueFE\*p-valueFE\*p-valueFE\*p-valueFE\*p-valueFE\*p-valueDNA metabolic process4.77.0E-215.88.8E-243.33.8E-171.63.3E-02------------cell cycle3.06.3E-193.81.7E-232.51.3E-181.92.4E-05------------DNA replication6.92.0E-189.21.7E-224.51.4E-142.62.0E-03------------chromosome segregation7.31.5E-138.92.5E-145.41.6E-133.45.8E-04------2.72.4E-02DNA repair5.02.1E-116.21.1E-123.31.8E-08----------------mitosis3.41.3E-104.44.6E-132.85.6E-112.19.3E-04------------catabolic process2.22.1E-072.31.4E-061.71.5E-051.82.5E-04------------cellular process1.29.6E-071.24.1E-061.16.6E-031.21.7E-04------1.32.1E-07ion transport2.23.5E-04------1.65.0E-032.45.0E-05------------cytokinesis2.92.7E-033.24.5E-032.01.9E-022.42.2E-02------------metabolic process1.26.1E-061.31.7E-061.26.3E-07----------------cellular component movement2.63.4E-062.56.1E-051.98.0E-052.16.3E-04------2.72.9E-05lipid metabolic process1.61.6E-02------2.62.8E-132.13.2E-05------2.31.1E-04response to stress1.62.2E-031.71.1E-031.46.1E-03------------1.51.9E-02anion transport2.31.7E-03------1.71.4E-022.92.6E-05------------cellular component morphogenesis2.01.3E-041.71.1E-02------2.38.7E-063.18.7E-052.32.6E-04macrophage activation------------------3.78.1E-053.53.0E-023.43.0E-03system development------------------1.69.5E-041.81.5E-021.72.4E-03immune system process------------------1.41.2E-02------2.22.3E-08developmental process------------------1.31.5E-02------1.76.1E-05cell proliferation------------------2.22.6E-02------6.16.1E-09signal transduction----------------------------1.75.5E-07cell communication----------------------------1.61.7E-06cell adhesion------------------26.5E-04------2.61.2E-05Abbreviations: DEG, differentially expressed gene; FE, Fold Enrichment is the number of DEGs involved in each GO biological process term divided by the expected number. -- Denotes non-significant term.

At 96 h post-operatively, there were 657 (493↑, 164↓), 448 (387↑, 61↓), and 211 (179↑, 32↓) genes for ALPPS, PH and PVL, respectively, when compared with the Sham livers (FDR \< 5% and FC \> 2) (Fig. [1a](#Fig1){ref-type="fig"}, Supplementary Table [S3](#MOESM1){ref-type="media"}). The ALPPS vs Sham produced the largest number of DEGs. Genes responsible for cell cycle, ion transport, mitosis, and organelle fission seemed to be highly enriched in the up-regulated genes in the ALPPS; genes responsible for cell activation, response to wounding, and immune response seemed to be the most significantly enriched in the PH. The down-regulated genes at 96 h, especially for the ALPPS and PH, were enriched for oxidation-reduction, metabolic process and inflammatory response (Fig. [2b](#Fig2){ref-type="fig"}). The cell adhesion, immune system process, cellular process and cell proliferation associated genes were significantly enriched after ALPPS and PH, and macrophage activation, system development, and cellular component and morphogenesis were significant after all the procedures at 96 h (Table [1](#Tab1){ref-type="table"}).

Common gene signatures of liver regeneration at 24 h and 96 h {#Sec10}
-------------------------------------------------------------

Among the all surgical procedures, 411 DEGs (351↑, 60↓) and 105 DEGs (99↑, 6↓) were dysregulated at 24 h and 96 h, respectively (FDR \< 5% and absolute FC \> 2) (Supplementary Fig. [S2A](#MOESM1){ref-type="media"}, Tables [S2](#MOESM1){ref-type="media"} and [S3](#MOESM1){ref-type="media"}, respectively). GO enrichment and functional analyses of DEGs at 24 h indicated involvement of genes related to cell cycle, DNA replication and repair, cell division, mitosis, and DNA metabolic process (Table [1](#Tab1){ref-type="table"}, Fig. [3](#Fig3){ref-type="fig"}, and Supplementary Fig. [S2B](#MOESM1){ref-type="media"}). Furthermore, the gene network, functional and pathway analyses revealed potentially important roles of *Ccnb1, Cdk1, E2f1, Ccna2, Rrm2, Lcn2*, NF-κB, and *Vegf* in liver regeneration and alterations in cell cycle and p53 pathways (Fig. [3a--c](#Fig3){ref-type="fig"} and Supplementary Fig. [S3](#MOESM1){ref-type="media"}).Figure 3Gene interaction network, functional, and canonical pathway analyses (**a--c**, respectively) at 24h and (**d--f**, respectively) at 96h of common DEGs among ALPPS, PH and PVL. Red and green denote up- and down-regulated genes, respectively, and grey indicates direct interactors of the DEGs. The sizes of nodes (in **a**) are proportional to their betweenness centrality values^[@CR22]^. Straight and dashed lines (in **d**) represent direct or indirect gene to gene interactions, respectively. The color intensity is correlated with fold change. X-axis (in bar graphs) indicates the significance (--log10(p-value)) of the functional/pathway association. The threshold line represents a P value of 0.05.The network (in **d**) and functional/pathway analyses were generated using IPA (QIAGEN Inc., <https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis>).

At 96 h, the DEGs that are commonly regulated in all surgical groups were mostly up-regulated (94%) and mainly involved in cellular movement, system development, extracellular matrix organization, and immune response (Supplementary Fig. [S2B](#MOESM1){ref-type="media"}). The gene ontology and network analyses indicated enrichment of genes related to cell death and survival, cellular growth and proliferation, lipid metabolism, and immune cell trafficking, including genes such as *LGALS3, FCGR2A, SPARC*, *Integrin*, and *Collagens* (p-value \<0.01) (Fig. [3d--f](#Fig3){ref-type="fig"}), at 96 h post-operations.

Functional, pathway and gene network comparison of temporal changes after ALPPS, PH and PVL {#Sec11}
-------------------------------------------------------------------------------------------

We further performed an extensive comparison of functional enrichment and gene networks for the three surgical procedures using different bioinformatics tools to further investigate molecular similarities/differences of the procedures as well as to investigate temporal changes within each surgical procedure at two time points.

Genes related to cell cycle, mitotic cell cycle, M phase, and DNA replication and repair were significantly enriched among the up-regulated genes at 24 h for all surgical procedures (Fig. [2a](#Fig2){ref-type="fig"}, Table [2](#Tab2){ref-type="table"}, and Supplementary Fig. [S4](#MOESM1){ref-type="media"}). However, genes related to oxidation-reduction, triglyceride, and steroid metabolic processes were the most critically enriched among the down-regulated genes in ALPPS and PH only. On the other hand, at 96 h, genes responsible for cell cycle and organelle fission seemed to be highly enriched in the up-regulated genes in the ALPPS; genes responsible for cell activation, response to wounding, and immune response seemed to be the most significantly enriched in the PH. The down-regulated genes at 96 h, especially for the ALPPS and PH, were enriched for oxidation-reduction, metabolic process and inflammatory response (Fig. [2b](#Fig2){ref-type="fig"}).Table 2Significantly altered canonical pathways, molecular and cellular functions, and predicted upstream regulators associated with DEGs in ALPPS, PVL and PH at 24 h and 96 h.ALPPS at 24 hrALPPS at 96 hrCanonical Pathwaysp-valueOverlapCanonical Pathwaysp-valueOverlapCell Cycle Control of Chromosomal Replication1.51E-1451.9% 14/27LPS/IL-1 Mediated Inhibition of RXR Function8.00E-069.5% 21/221Mitotic Roles of Polo-Like Kinase1.07E-1430.3% 20/66Mitotic Roles of Polo-Like Kinase6.53E-0616.7% 11/66Role of BRCA1 in DNA Damage Response3.84E-1224.4% 19/78FXR/RXR Activation1.10E-0511.9% 15/126Cell Cycle: G2/M DNA Damage Checkpoint Regulation1.37E-1232.7% 16/49Hepatic Fibrosis / Hepatic Stellate Cell Activation2.47E-048.7% 16/183**Upstream Regulatorsp-valuePredicted ActivationUpstream Regulatorsp-valuePredicted Activation**E2F14.93E-41ActivatedERBB24.36E-22ActivatedCCND12.35E-40ActivatedTGFB15.96E-22ActivatedRABL66.32E-38ActivatedVEGF8.37E-21ActivatedCDKN1A2.73E-57InhibitedCSF27.02E-16ActivatedTP536.98E-53InhibitedCDKN1A3.22E-24Inhibited**Molecular and Cellular Functionsp-value range\# MoleculesMolecular and Cellular Functionsp-value range\# Molecules**Cell Cycle2.22E-05 - 5.88E-29209Cell Death and Survival4.43E-04 - 4.11E-16257Cellular Assembly and Organization2.88E-05 - 6.87E-26186Cell Cycle4.19E-04 - 4.78E-15135DNA Replication, Recombination, and Repair2.22E-05 - 6.87E-26173Cellular Assembly and Organization4.64E-04 - 4.78E-15176Cell Death and Survival2.88E-05 - 1.12E-18278DNA Replication, Recombination, and Repair4.19E-04 - 4.78E-15107Cell Morphology2.88E-05 - 4.40E-15145Cellular Growth and Proliferation4.61E-04 - 3.22E-15287**Physiological System Development and Functionp-value range\# MoleculesPhysiological System Development and Functionp-value range\# Molecules**Organismal Development1.15E-06 - 4.56E-0919Cardiovascular System Development and Function2.79E-04 - 5.36E-09119Connective Tissue Development and Function1.74E-05 - 1.02E-1092Tissue Development3.41E-04 - 6.93E-09211Tissue Development2.30E-05 - 5.37E-10106Immune Cell Trafficking2.77E-04 - 1.04E-0885Tissue Morphology2.22E-05 - 4.56E-0930Hematological System Development and Function2.77E-04 - 3.13E-08112Embryonic Development1.15E-06 - 4.56E-0919Organismal Development3.38E-04 - 9.93E-08128**Tox Listsp-valueOverlapTox Listsp-valueOverlap**Cell Cycle: G2/M DNA Damage Checkpoint Regulation3.86E-1230.8% 16/52Renal Necrosis/Cell Death2.36E-077.7% 40/519Liver Proliferation4.84E-069.6% 22/228LPS/IL-1 Mediated Inhibition of RXR Function1.49E-0710.3% 26/253Aryl Hydrocarbon Receptor Signaling9.04E-0711.9% 19/159FXR/RXR Activation1.10E-0511.9% 15/126CAR/RXR Activation2.58E-0627.6% 8/29Cardiac Hypertrophy1.39E-067.8% 34/435**PVL at 24 hrPVL at 96 hrCanonical Pathwaysp-valueOverlapCanonical Pathwaysp-valueOverlap**Cell Cycle Control of Chromosomal Replication3.16E-1651.9% 14/27GADD45 Signaling9.30E-0415.8% 3/19Mitotic Roles of Polo-Like Kinase9.19E-1628.8% 19/66Purine Ribonucleosides Degradation to Ribose-1-phosphate2.85E-0325.0% 2/8Role of BRCA1 in DNA Damage Response3.60E-1323.1% 18/78GDP-glucose Biosynthesis3.64E-0322.2% 2/9Estrogen-mediated S-phase Entry2.95E-1245.8% 11/24Glucose and Glucose-1-phosphate Degradation4.52E-0320.0% 2/10Cell Cycle: G2/M DNA Damage Checkpoint Regulation3.67E-1330.6% 15/49Mitotic Roles of Polo-Like Kinase4.83E-036.1% 4/66**Upstream Regulatorsp-valuePredicted ActivationUpstream Regulatorsp-valuePredicted Activation**E2F16.82E-48ActivatedTGFB17.66E-11ActivatedRABL61.67E-42ActivatedCSF21.20E-07ActivatedCCND12.68E-41ActivatedIL43.51E-06ActivatedCDKN1A9.47E-67InhibitedSMARCA45.42E-06ActivatedTP531.14E-63InhibitedMYCN8.83E-04Inhibited**Molecular and Cellular Functionsp-value range\# MoleculesMolecular and Cellular Functionsp-value range\# Molecules**Cell Cycle1.57E-05 - 4.47E-38202Cell Death and Survival9.04E-03 - 1.69E-0996Cellular Assembly and Organization1.48E-05 - 3.39E-34163Cellular Growth and Proliferation8.25E-03 - 3.76E-09106DNA Replication, Recombination, and Repair1.43E-05 - 3.39E-34160Cellular Assembly and Organization8.66E-03 - 3.93E-0762Cell Death and Survival1.47E-05 - 5.70E-21224Cell Morphology9.04E-03 - 7.52E-0767Cell Morphology1.44E-05 - 5.49E-17107Cell-To-Cell Signaling and Interaction8.89E-03 - 1.32E-0644**Physiological System Development and Functionp-value range\# MoleculesPhysiological System Development and Functionp-value range\# Molecules**Reproductive System Development and Function1.43E-05 - 9.48E-1252Tissue Development8.89E-03 - 3.93E-0792Organismal Development6.34E-09 - 4.28E-1119Lymphoid Tissue Structure and Development8.18E-03 - 4.34E-0635Connective Tissue Development and Function1.07E-05 - 8.94E-1181Organ Morphology8.89E-03 - 4.34E-0638Tissue Morphology5.72E-06 - 4.28E-1150Cardiovascular System Development and Function7.67E-03 - 1.32E-0647Embryonic Development1.14E-05 - 4.28E-1134Tissue Morphology8.46E-03 - 4.34E-0665**Tox Listsp-valueOverlapTox Listsp-valueOverlap**Cell Cycle: G2/M DNA Damage Checkpoint Regulation9.76E-1328.8% 15/52Nongenotoxic Hepatocarcinogenicity Biomarker Panel6.98E-0518.2% 4/22Increases Liver Hyperplasia/Hyperproliferation1.29E-0612.6% 13/103Recovery from Ischemic Acute Renal Failure (Rat)3.63E-0421.4% 3/14Aryl Hydrocarbon Receptor Signaling6.67E-0811.3% 18/159Cardiac Hypertrophy6.20E-043.0% 13/435Cell Cycle: G1/S Checkpoint Regulation5.04E-0716.7% 11/66Increases Renal Damage1.52E-036.2% 5/81**PH at 24 hrPH at 96 hrCanonical Pathwaysp-valueOverlapCanonical Pathwaysp-valueOverlap**Cell Cycle Control of Chromosomal Replication2.21E-1563.0% 17/27Production of Nitric Oxide and Reactive Oxygen Species in Macrophages5.40E-0910.4% 20/193Role of BRCA1 in DNA Damage Response2.90E-1230.8% 24/78LXR/RXR Activation5.62E-0913.2% 16/121Mitotic Roles of Polo-Like Kinase3.83E-1233.3% 22/66Acute Phase Response Signaling1.18E-0710.1% 17/169Hereditary Breast Cancer Signaling4.47E-1121.8% 31/142Phagosome Formation1.08E-059.8% 12/122Cell Cycle: G2/M DNA Damage Checkpoint Regulation5.42E-1136.7% 18/49Fc Receptor-mediated Phagocytosis in Macrophages and Monocytes2.70E-0510.8% 10/93**Upstream Regulatorsp-valuePredicted ActivationUpstream Regulatorsp-valuePredicted Activation**CCND14.01E-37ActivatedTNF4.33E-30ActivatedE2F15.13E-34ActivatedIFNG2.25E-22ActivatedRABL61.42E-33ActivatedTP531.60E-21ActivatedCDKN1A2.64E-47InhibitedIL66.78E-20ActivatedTP537.48E-47InhibitedIL1B4.93E-19Activated**Molecular and Cellular Functionsp-value range\# MoleculesMolecular and Cellular Functionsp-value range\# Molecules**Cell Cycle6.16E-05 - 1.88E-28281Cellular Movement8.64E-06 - 1.06E-28161Cellular Assembly and Organization6.85E-05 - 1.88E-28163Cellular Growth and Proliferation1.01E-05 - 2.44E-24228DNA Replication, Recombination, and Repair6.85E-05 - 1.88E-28243Cell Death and Survival9.36E-06 - 3.12E-23201Cell Death and Survival7.54E-05 - 6.73E-17420Cell-To-Cell Signaling and Interaction7.47E-06 - 4.76E-20133Cell Morphology1.58E-05 - 4.68E-15229Cellular Function and Maintenance6.05E-06 - 4.83E-17187**Physiological System Development and Functionp-value range\# MoleculesPhysiological System Development and Functionp-value range\# Molecules**Organismal Survival1.95E-06 - 3.67E-09292Hematological System Development and Function9.36E-06 - 1.66E-27177Reproductive System Development and Function3.04E-05 - 3.16E-1027Immune Cell Trafficking8.64E-06 - 4.34E-28120Connective Tissue Development and Function5.16E-05 - 8.45E-11132Cardiovascular System Development and Function9.16E-06 - 2.79E-19120Tissue Development6.77E-05 - 8.45E-11117Organismal Development7.85E-06 - 5.64E-17154Embryonic Development7.74E-06 - 3.42E-0727Tissue Morphology9.16E-06 - 8.60E-20158**Tox Listsp-valueOverlapTox Listsp-valueOverlap**Cell Cycle: G2/M DNA Damage Checkpoint Regulation1.71E-1034.6% 18/52Positive Acute Phase Response Proteins3.28E-1033.3% 10/30LPS/IL-1 Mediated Inhibition of RXR Function2.44E-0915.8% 40/253LXR/RXR Activation7.16E-0913.0% 16/123Fatty Acid Metabolism5.33E-0921.4% 25/117Cardiac Necrosis/Cell Death1.60E-067.3% 20/273Aryl Hydrocarbon Receptor Signaling1.51E-0818.2% 29/159Cardiac Hypertrophy6.76E-076.2% 27/435Xenobiotic Metabolism Signaling2.97E-0611.9% 42/352Acute Renal Failure Panel (Rat)5.80E-0614.5% 9/62

The DEGs for each procedure at each time point were mapped to gene interaction networks in order to obtain deeper insights into the interactions of these genes among various pathways. The functional, pathway and gene network analyses highlighted the potentially critical genes, biological processes, and signaling pathways for the temporal changes within ALLPS, PVL, and PH groups (Table [2](#Tab2){ref-type="table"}, Supplementary Fig. [S4](#MOESM1){ref-type="media"}). Cell cycle, mitosis, and DNA replication, process-related genes, such as *Cdk1, E2f1, Ezh2, Ccnb1, Cdkn1a*, *Myc*, and p53 pathways were significantly regulated at 24 h in all procedures. The networks for ALLPS and PH were more similar than PVL at early phase of the regeneration, corroborating with the clustering results in Fig. [1](#Fig1){ref-type="fig"} and Supplementary Fig. [S1](#MOESM1){ref-type="media"}. At 96 h, cell proliferation, cell cycle, mitosis and cell division remained active in the ALPPS when compared to the PH and PVL. Genes related to macrophage activation, anion transport, immune response, lipid metabolic process were also significantly regulated in the ALPPS (Table [1](#Tab1){ref-type="table"}, Supplementary Fig. [S4](#MOESM1){ref-type="media"}). Significantly altered pathways included the FXR/RXR activation, cell cycle and integrin signaling pathways in the ALPPS group at 96 h. On the other hand, cellular movement, immune cell trafficking, and signal transduction related genes and T-cell activation and Ras pathways were significantly altered in the PH group at 96 h. Top five significant molecular and cellular functions, canonical pathways, and predicted upstream regulators (activated/inhibited) for each surgical procedure at two time points are given in Table [2](#Tab2){ref-type="table"}. Furthermore, the complete list of significant PANTHER and canonical pathways are given in Table [3](#Tab3){ref-type="table"} and Supplementary Table [S4](#MOESM1){ref-type="media"}, respectively.Table 3Significantly altered pathways in ALPPS, PVL and PH at 24 h and 96 h post operation.ALPPS at 24 hrALPPS at 96 hrPANTHER PathwaysDEGsFEP-valuePANTHER PathwaysDEGsFEP-valueProline biosynthesis216.66.7E-03N-acetylglucosamine metabolism316.88.3E-04De novo pyrimidine deoxyribonucleotide biosynthesis615.33.5E-06Adenine and hypoxanthine salvage pathway312.61.9E-03Formyltetrahydroformate biosynthesis314.21.3E-03Pyruvate metabolism59.91.8E-04DNA replication117.92.4E-07Formyltetrahydroformate biosynthesis29.61.9E-02Plasminogen activating cascade35.91.5E-025-Hydroxytryptamine degredation34.82.6E-02Cell cycle45.37.3E-03Axon guidance mediated by semaphorins34.23.6E-02Cytoskeletal regulation by Rho GTPase104.02.7E-04Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway133.69.5E-05Blood coagulation53.51.5E-02Angiotensin II-stimulated signaling through G proteins and beta-arrestin43.23.8E-02p53 pathway123.25.6E-04Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway122.54.2E-03p53 pathway feedback loops 252.83.7E-02Alzheimer disease-presenilin pathway92.32.1E-02Alzheimer disease-presenilin pathway112.72.9E-03Integrin signalling pathway132.27.5E-03**PVL at 24 hrPVL at 96 hrPANTHER PathwaysDEGsFEP-valuePANTHER PathwaysDEGsFEP-value**Formyltetrahydroformate biosynthesis319.15.7E-04p53 pathway43.33.6E-02De novo pyrimidine deoxyribonucleotide biosynthesis517.21.4E-05Axon guidance mediated by semaphorins28.62.3E-02Phenylethylamine degradation212.81.1E-02Beta3 adrenergic receptor signaling pathway27.13.3E-02DNA replication1110.71.3E-08Opioid prodynorphin pathway26.24.2E-02Cell cycle47.12.6E-03Cortocotropin releasing factor receptor signaling pathway26.24.2E-02p53 pathway feedback loops 275.24.8E-04Opioid proopiomelanocortin pathway26.14.4E-02De novo purine biosynthesis34.62.8E-02Opioid proenkephalin pathway26.14.4E-02p53 pathway113.91.7E-045HT4 type receptor mediated signaling pathway26.14.4E-02Blood coagulation43.82.2E-02Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway43.43.1E-02Cytoskeletal regulation by Rho GTPase52.74.1E-02**PH at 24 hrPH at 96 hrPANTHER PathwaysDEGsFEP-valuePANTHER PathwaysDEGsFEP-value**Proline biosynthesis314.31.3E-03N-acetylglucosamine metabolism325.12.6E-04Phenylethylamine degradation38.16.3E-03Pyruvate metabolism411.84.1E-04Formyltetrahydroformate biosynthesis38.16.3E-03Plasminogen activating cascade38.95.0E-03Vitamin B6 metabolism27.62.9E-02Axon guidance mediated by semaphorins48.41.5E-03Salvage pyrimidine deoxyribonucleotides27.62.9E-02Blood coagulation55.42.7E-03De novo pyrimidine deoxyribonucleotide biosynthesis57.37.1E-04Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway114.64.1E-05DNA replication166.66.5E-09Enkephalin release34.23.6E-02Pyruvate metabolism44.51.3E-02Ras Pathway63.85.8E-03Androgen/estrogene/progesterone biosynthesis34.13.9E-02VEGF signaling pathway53.31.9E-02Cell cycle53.81.1E-02Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway103.11.9E-03Blood coagulation93.61.1E-03Interleukin signaling pathway63.11.5E-025-Hydroxytryptamine degredation43.62.6E-02Cytoskeletal regulation by Rho GTPase53.02.6E-02Cytoskeletal regulation by Rho GTPase122.81.9E-03Angiogenesis102.83.9E-03p53 pathway feedback loops 282.51.6E-02PDGF signaling pathway82.71.1E-02p53 pathway152.33.5E-03CCKR signaling map92.69.6E-03T cell activation52.55.0E-02Inflammation mediated by chemokine and cytokine signaling pathway132.52.4E-03Abbreviations: DEGs, number of differentially expressed genes with respect to Sham; FE, Fold Enrichment is the number of DEGs involved in each pathway divided by the expected number.

Temporal pattern of upstream transcriptional regulators after ALPPS, PH and PVL {#Sec12}
-------------------------------------------------------------------------------

We identified the transcriptional regulators likely to be involved in the regenerating liver after each surgical procedure at two time points (Fig. [4](#Fig4){ref-type="fig"}). The IPA upstream regulator analytic identifies the upstream transcriptional regulators and mechanistic networks that can explain the gene expression changes observed after each procedure. There were 184, 158, and 206 upstream regulators predicted to be activated or inhibited after ALPPS, PH, and PVL, respectively at 24 hr (Fig. [4a](#Fig4){ref-type="fig"}). There was a noteworthy overlap of transcriptional regulators between different procedures at 24 h. The inter-procedural variations in ALPPS, PVL and PH are displayed at 24 h and 96 h (in Fig. [4b,c](#Fig4){ref-type="fig"}, respectively) for the top 15 activated upstream regulators. The union of top 15 activated upstream regulators in ALPPS, PVL and PH at 24 h and 96 h is used for the heatmap. Similarly, the temporal variations in each procedure are also investigated for ALPPS, PH and PVL, in Fig. [4d--f](#Fig4){ref-type="fig"}, respectively. Figure [4](#Fig4){ref-type="fig"} also displays the heatmap of the top 50 activated/inhibited upstream regulators across all samples to investigate the temporal changes for the three procedures (complete list is given in Supplementary Table [S5](#MOESM1){ref-type="media"}) (Fig. [4g](#Fig4){ref-type="fig"}).Figure 4The upstream regulator analyses. (**a**) Venn diagrams representing the overlap of predicted upstream regulators that are unique or common among ALPPS, PH and PVL at 24 h (top) and 96 h (bottom). **(b,c)** Inter-procedural variations at 24 h and 96 h, respectively. (**d--f**) Temporal variations after ALPPS, PH and PVL, respectively. Heatmaps for union of top 15 activated upstream regulators in ALPPS, PVL and PH at 24 h and 96 h are used. Color scale shows significance by --log10(p-value). **(g)** Heatmap that displays surgical procedure as well as temporal changes for the top 50 activated/inhibited upstream regulators. The upstream regulators are ordered according to significance in ALPPS procedure. The color-key is for the z-score. Data were analyzed through the use of IPA (QIAGEN Inc., <https://www.qiagenbioinformatics.com/products/ingenuitypathway-analysis>).

Activated regulators, such as *E2F1, CCND1, TBX2, RABL6, MYC, EP400, Vegf, FOXM1*, HGF, and *IL6*, and inhibited regulators, including *CDKN1A, NUPR1, Rb, HNF4A*, and *TP53*, may play important roles for early liver regeneration (Fig. [4](#Fig4){ref-type="fig"}). *TGFB, KRAS, IL1, ERK1/2* appears to be activated in ALLPS and PH (Fig. [4g](#Fig4){ref-type="fig"} and Supplementary Table [S5](#MOESM1){ref-type="media"}). On the other hand, at 96 h, *CSF2, Cg, TGFB1, IFNG, IL5*, and *F2* were predicted to be activated in all procedures. *FOXM1, PTGER2, E2F3, TBX2, CCND1, E2F1*, and *Notch* were activated significantly in the ALPPS; *TNF, TP53, STAT3, PDGF*, and *IL1A* in the PH; *JUN* and *POU5F1* in the PVL. *Vegf, HGF, IL6, IL1B, NFKB*, *IFNA*, and *MITF* were activated both in ALPPS and PH (Fig. [4](#Fig4){ref-type="fig"} and complete list in Supplementary Table [S5](#MOESM1){ref-type="media"}). There were 101 and 23 shared regulators among the procedures at 24 h and 96 h, respectively (Fig. [4a](#Fig4){ref-type="fig"} and Supplementary Table [S5](#MOESM1){ref-type="media"}). The upstream regulator analysis also revealed several activated mechanistic networks at early and late-stage of liver regeneration, including *E2F1, HGF* and *TP53* at 24 h and *TGFB1, Vegf*, and *TP53* at 96 h (Fig. [5](#Fig5){ref-type="fig"}).Figure 5Mechanistic networks of upstream regulators and their predicted relationship by IPA®. The networks for top upstream regulators: E2F1, HGF and TP53 at 24 h and TGFB1, Vegf, and TP53 at 96 h are shown.

Discussion {#Sec13}
==========

We performed next-generation RNAseq approach to comprehensively delineate liver regeneration induced by ALPPS, PVL, and PH approaches at two time points (24 h and 96 h). Recently, we have replicated ALPPS in a rat model and presented its quick rejuvenation mode^[@CR17]^. In this study, we identified pertinent common transcriptomic signatures at critical time points (i.e. early proliferation and late-proliferation phase) of liver regeneration and revealed the inter-procedural and temporal variations in gene expression patterns.

In response to injury, liver regeneration is achieved by the activation of otherwise functional, fully-differentiated hepatocytes as a result of the autocrine and paracrine signaling (e.g., cytokines and growth factors)^[@CR12],[@CR17]^. Thus, major underlying changes in gene networks are expected to be seen at the cellular level. Depending on the initial injurious stimulus (or surgical procedure), such networks may have distinct elements as well as shared factors that are critical for regeneration. Therefore, delineation of the gene networks in liver regeneration is of particular interest. Moreover, understanding of signaling cascades and gene networks of the ALPPS, PVL and PH at 24 hours is vital as these may be critical factors for the initiation of regeneration or resulting in poor recovery, incomplete regeneration, and ultimately, liver failure.

Our data revealed that time-dependent factors appear to be the major source of variation in post-injury alterations of gene expression in liver regeneration. Early transcriptomic changes and the upstream regulators after all the procedures included cell cycle associated genes (*E2F1, CCND1, FOXM1, TP53*, and *RB1*), transcription factors (*Myc, E2F1, TBX2, FOXM1*)^[@CR23]--[@CR28]^, DNA replication regulators (*CDKN1A, EZH2, RRM2*)^[@CR29]^, G1/S-transition regulators (*CCNB1, CCND1, RABL6*)^[@CR30]^, cytokines and growth factors (*CSF2, IL-6, TNF, HGF, VEGF*, and *EGF*)^[@CR9],[@CR16],[@CR31],[@CR32]^. At the cellular level, this corresponds to the transition from the quiescent G0 phase to active mitosis. Liver regeneration is governed by numerous growth factors, including HGF and EGF that are responsible priming the parenchymal and nonparenchymal liver cells and boosting their access into the cell cycle to proliferate to restore the original liver size after the surgical procedures^[@CR9],[@CR16],[@CR31],[@CR32]^. Growth factors and signaling pathways activates cyclin-dependent kinases (CDKs), and upregulates the expression of *CCND1* that encodes cyclin D1. *CDK1* is essential for DNA replication and downstream formation of replication-initiation complexes in hepatocytes and shown to play a critical role in DNA replication control during rat liver regeneration following PH^[@CR33]^. It is also required for the activity of *CCNB1*, a protein from cyclin regulatory proteins family that is essential for cell cycle control during G2/M (mitosis) transition.

Upstream events that can induce the quiescence-to-mitosis transition may potentially be important in liver regeneration, such as activation of *E2F1, CCND1, FOXM1*, and inhibition of *TP53*, and *RB1*. Notably, enhancer of zeste homolog 2 (*EZH2*) was among the early significantly up-regulated genes. As the functional subunit of Polycomb Repressive Complex 2 (*PRC2*), which normally regulates development and differentiation in healthy embryonic tissue, it is potentially involved in early de-differentiation that hepatocytes undergo to become highly proliferative^[@CR34]^. Additionally, its up-regulation is consistent with the decreased lipid metabolism identified by our functional network analysis^[@CR35]^. As a specialized function of hepatocytes, the decrease in lipid metabolism may well be an indication of dedifferentiation. Besides the critical inducers of dedifferentiation and G0-to-G1 transition, other molecules seem to be critical in sustaining a robust intracellular environment. One example is p400 E1A-associated protein (*EP400*), which was predicted to be an early upstream regulator. *EP400* is essential for the control of reactive oxygen species (ROS) intracellularly, maintaining an oxidative-stress free environment without which DNA damage, senescence, and apoptosis may ensue^[@CR36]^. Another example is Lipocalin 2 (*LCN2*), an innate-immunity molecule with iron-sequestering properties. It has a wide expression in various tissues but has been particularly used as an early biomarker for kidney injury^[@CR37]^. Recently, the increased expression level of *LCN2* has been demonstrated in acute liver injury as well^[@CR38]--[@CR40]^. Indeed, protein and mRNA levels of *Lcn2* is significantly increased after partial hepatectomy^[@CR41]^.

Immune mediators of liver regeneration that showed a significant increase in expression immediately after the operations were *IL-6* and *VEGF*^[@CR17],[@CR42]--[@CR44]^. These molecules are known mediators of acute and chronic inflammatory response, carrying out essential functions in repairing tissue injury in all parts of the human body. *IL-6*, secreted by macrophages, is a known pyrogen and a potent stimulator of the acute phase reactants following infection or trauma. *VEGF* is secreted by endothelial cells to promote vasculogenesis and angiogenesis. In liver injury, *VEGF* mediates the proliferation and mobilization of liver sinusoidal endothelial cell progenitor cells form the bone marrow to allow for the formation of new sinusoids in the regenerating, highly-vascular liver tissue^[@CR45]^.

The network analysis of up-regulated genes at 96 h post-operatively revealed an expression profile predominantly in mediating tissue reconstruction, including cellular movement, system development, extracellular matrix organization and restoring specialized hepatocytic functions (e.g., carbohydrate transport and morphogenesis). Of note, this phase seems to be orchestrated by the macrophages (known as Kuppfer cells in the liver). Transforming growth factor-β *(TGF-β)*, a potent inhibitor of inflammation and a stimulator of healing and tissue repair that is secreted by macrophages, was significantly up-regulated at 96 h. Furthermore, the analysis also highlighted genes such as *LGALS3, FCGR2A, SPARC, integrin*, and *collagens*, that may play significant roles in tissue regeneration and repair^[@CR46]--[@CR48]^. These genes closely coordinate their function with *TGF-β* in tissue organization, matrix structure and cell-to-cell interactions. The knockout mice of secreted protein acidic and rich in cysteine (*SPARC*) showed a reduction of expression of *TGF-β1* and collagen in hepatic tissue^[@CR49]^.

Among the three examined procedures, as noted in the clustering and upstream regular analyses, ALPPS and PH shared many significantly regulated genes whose expression were not otherwise significantly changed in PVL, especially at the early phase of regeneration. One possible explanation lies in the differences of the type of injury caused by each procedure. Specifically, ALPPS and PH both require the removal of hepatic parenchyma. On the other hand, the main stimulant of regeneration in PVL is ischemia and oxygen deprivation. Clinically, PVL is the least invasive and has the lowest rate of morbidity and mortality but also has a slower rate of regeneration than the other procedures^[@CR50]^. Compared to PVL, the upstream regulator analysis revealed the activation of *TGF-β, KRAS, ERK1/2, IL1*, and *INS* at early phase and *Vegf, HGF, Interferan alpha, IL6*, *IL1B*, and *NFKB* at the later regeneration phase after ALPPS and PH. On the other hand, compared to PH and PVL, the cell cycle associated genes, cytokines, and transcription regulators, such as *E2F1, TBX2, FOXM1*, and *EP400*, are still activated after ALPPS at later regeneration phase. Finally, the Notch signaling, which is a complex signaling pathway that is crucial for the development of multiple organs, was also seemed to be activated in ALPPS. In the liver, it controls the hepatic cell differentiation into, and the formation of, the biliary system^[@CR51]^. In addition, notch proteins have an extracellular membrane component with epidermal growth-like factor (*EGF*) repeats, which may be responsible for the high growth rate seen clinically in ALPPS^[@CR52]^.

The upstream analyses also indicated the predicted inhibition of *NUPR1, CDKN2A, Rb, PAX6*, and *TP53*, at initial phase of liver regeneration^[@CR53],[@CR54]^. However, at the later stage of liver regeneration, *TP53* is activated, especially after PH. Furthermore, the mechanistic network of upstream regulators and their predicted relationship based on the observed gene expression changes in our data reveals the working mechanism of TP53 at early and late stage of the liver regeneration, as demonstrated in Fig. [5](#Fig5){ref-type="fig"}. p53 regulates liver homeostasis, and initiation of cell proliferation through proliferative signaling and disruption of p53 signaling lead to faster recovery^[@CR53],[@CR54]^.

The limitation of the study is that we examined the liver proliferation at two time points, early phase (i.e. 24 h) and late-stage (i.e. 96 h). Our earlier study of ALPPS and PVL indicated higher proliferation index (PI) at 24 h and 48 hr comparing to 96 h, and there was no significant difference between the two time-points (i.e. 24 h vs. 48 h)^[@CR17]^. The future remnant liver volume (FRLV) ratio was significantly higher in ALPPS comparing to PVL at 24 hr and 96 hr time points, but not significantly different at 48 h or 1 week. Higher FRL ratio is critical factor in improving surgical outcomes and liver regeneration. In addition, the ALPPS model has significantly more inflammatory cells infiltration at 24 hr comparing to 48 hr; higher infiltration of inflammatory might promoted earlier liver regeneration in the ALPPS model. It also indicated higher portal pressure in ALPPS group at 24 hr comparing to other time points; having higher portal pressure might act as physical stressor that contribute to ignite the regeneration process. Xu *et al*. studied the expressed genes in regenerating rat liver after PH, also reported that temporal patterns of gene expression were similar at 48 h and 96 h after PH^[@CR55]^. Nevertheless, more time points should worth to be assessed to fully investigate the liver proliferation process. While recognizing this limitation, we believe we have largely achieved our aim, as the major objective of the study is to fish out early phase (i.e. 24 h) and late-stage (i.e. 96 h) liver regeneration molecular markers and examining molecular differences between these phases in the ALPSS, PVL and PH models that have provided unique molecular signatures.

In summary, our study presents a comprehensive transcriptomic profiling of three surgical procedures that are commonly used in clinical practice and identified the inter-procedural and temporal variations in gene expression patterns in each surgical procedure. Identification of molecular signatures and signaling pathways specific to each surgical procedure further our understanding of key regulators of liver regeneration as well as patient populations that are likely to benefit from each procedure.
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